Dentsply Sirona (XRAY)

• Market cap: $2.57B
• 1 day: 0.78%
• 5 days: 1.02%
• 1 month: -18.23%
• 3 months: -33.26%
• 6 months: -46.79%
• Year to date: -31.09%
• 1 year: -57.46%
• 5 years: -67.63%
• 10 years: -75.31%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).

Employees: 14,000

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

61% more call options, than puts

Call options by funds: $19.9M | Put options by funds: $12.3M

0% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 4 (+0) [Q4]

0.97% less ownership

Funds ownership: 101.8% [Q3] → 100.83% (-0.97%) [Q4]

2% less repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 124

6% less funds holding

Funds holding: 378 [Q3] → 355 (-23) [Q4]

16% less first-time investments, than exits

New positions opened: 76 | Existing positions closed: 91

32% less capital invested

Capital invested by funds: $5.57B [Q3] → $3.8B (-$1.77B) [Q4]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $18 39% upside
• Avg. target: $19.40 50% upside
• High target: $20 55% upside

5 analyst ratings

• positive: 1 20%
• neutral: 4 80%
• negative: 0 0%

Mizuho Steven Valiquette 14% 1-year accuracy 1 / 7 met price target	39% upside $18	Neutral Maintained	13 Mar 2025
Wells Fargo Vik Chopra 27% 1-year accuracy 3 / 11 met price target	47% upside $19	Equal-Weight Maintained	28 Feb 2025
Barrington Research Michael Petusky 17% 1-year accuracy 12 / 70 met price target	55% upside $20	Outperform Maintained	28 Feb 2025
Baird Jeffrey Johnson 0 / 0 met price target	55% upside $20	Neutral Maintained	28 Feb 2025
Jefferies Glen Santangelo 45% 1-year accuracy 5 / 11 met price target	55% upside $20	Hold Downgraded	23 Jan 2025